Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000248651 | SCV000306731 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000841218 | SCV000983176 | benign | not provided | 2018-06-14 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000248651 | SCV001623112 | benign | not specified | 2021-04-30 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001543756 | SCV001762610 | benign | Sialuria | 2021-07-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001274435 | SCV001762611 | benign | GNE myopathy | 2021-07-10 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000841218 | SCV005265635 | benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV001274435 | SCV001458617 | benign | GNE myopathy | 2020-01-03 | no assertion criteria provided | clinical testing |